Lynn Seely (Myovant)
Lynn Seely hits the exit as Myovant graduates to commercial space — handing the reins to Amgen vet
When Lynn Seely took the helm at Myovant as the newly-retired chief medical officer of Medivation, the biotech was still a fledgling member of …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
